Spectral AI, Inc. (MDAI)

NCM – Real vaqt narxi. Valyuta: USD

1.71

+0.04 (2.40%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

1.74

+0.03 (1.75%)

Bozordan keyin: Jun 26, 2026, 7:55 PM EDT

12.06.2026

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month.

11.06.2026

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Company Will Showcase FDA-Cleared DeepView® System for Burn Indication Company Will Showcase FDA-Cleared DeepView® System for Burn Indication

01.06.2026

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

DALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026. The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from the U.S. Food and Drug Administration (“FDA”).

26.05.2026

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

DALLAS, May 26, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the U.S. Food and Drug Administration (FDA) granted De Novo Classification for its DeepView® System. With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States.

13.05.2026

Spectral AI Q1 Earnings Call Highlights

Spectral AI NASDAQ: MDAI said it remains on track toward potential U.S. regulatory clearance and commercialization of its DeepView system for burn assessment, while reporting lower first-quarter research and development revenue tied to the completion of work under a federal contract.

12.05.2026

Spectral AI, Inc. (MDAI) Q1 2026 Earnings Call Transcript

12.05.2026

Spectral AI Announces 2026 First Quarter Financial Results

Development Work for DeepView ® Systems Continues with Support of Recently Awarded $31.7 Million of Funding from BARDA

Videolar

No Data

There is no data to display

Press-relizlar

12.06.2026

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

11.06.2026

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Company Will Showcase FDA-Cleared DeepView® System for Burn Indication Company Will Showcase FDA-Cleared DeepView® System for Burn Indication

01.06.2026

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

26.05.2026

Spectral AI, Inc. (MDAI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Spectral AI, Inc. (MDAI)

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Q1 Earnings Call Highlights

Spectral AI, Inc. (MDAI) Q1 2026 Earnings Call Transcript

Spectral AI Announces 2026 First Quarter Financial Results

Videolar

No Data

Press-relizlar

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Q1 Earnings Call Highlights

Spectral AI, Inc. (MDAI) Q1 2026 Earnings Call Transcript

Spectral AI Announces 2026 First Quarter Financial Results

Videolar

No Data

Press-relizlar

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Search stocks

Spectral AI, Inc. (MDAI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Spectral AI, Inc. (MDAI)

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Q1 Earnings Call Highlights

Spectral AI, Inc. (MDAI) Q1 2026 Earnings Call Transcript

Spectral AI Announces 2026 First Quarter Financial Results

Videolar

No Data

Press-relizlar

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Spectral AI Q1 Earnings Call Highlights

Spectral AI, Inc. (MDAI) Q1 2026 Earnings Call Transcript

Spectral AI Announces 2026 First Quarter Financial Results

Videolar

No Data

Press-relizlar

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI to Participate in 2026 British Burn Association Annual Conference

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication